JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hou, Y.
Right arrow Articles by Mahuran, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hou, Y.
Right arrow Articles by Mahuran, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 33, 21386-21392, August 14, 1998

A Pro504 right-arrow  Ser Substitution in the beta -Subunit of beta -Hexosaminidase A Inhibits alpha -Subunit Hydrolysis of GM2 Ganglioside, Resulting in Chronic Sandhoff Disease

Yongmin HouDagger §, Beth McInnesDagger , Aleksander HinekDagger , George Karpati, and Don MahuranDagger §

From the Dagger  The Research Institute, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada, the § Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G 2C4, Canada, and the  Department of Neurology and Neurosurgery, McGill University and Montreal Neurological Institute, Montreal, Quebec H3A 2B4, Canada

The GM2 gangliosidoses are caused by mutations in the genes encoding the alpha - (Tay-Sachs) or beta - (Sandhoff) subunits of heterodimeric beta -hexosaminidase A (Hex A), or the GM2 activator protein (AB variant), a substrate-specific co-factor for Hex A. Although the active site associated with the hydrolysis of GM2 ganglioside, as well as part of the binding site for the ganglioside-activator complex, is associated with the alpha -subunit, elements of the beta -subunit are also involved. Missense mutations in these genes normally result in the mutant protein being retained in the endoplasmic reticulum and degraded. The mutations associated with the B1-variant of Tay-Sachs are rare exceptions that directly affect residues in the alpha -active site. We have previously reported two sisters with chronic Sandhoff disease who were heterozygous for the common HEXB deletion allele. Cells from these patients had higher than expected levels of mature beta -protein and residual Hex A activity, ~20%. We now identify these patients' second mutant allele as a C1510T transition encoding a beta -Pro504 right-arrow Ser substitution. Biochemical characterization of Hex A from both patient cells and cotransfected CHO cells demonstrated that this substitution (a) decreases the level of heterodimer transport out of the endoplasmic reticulum by ~45%, (b) lowers its heat stability, (c) does not affect its Km for neutral or charged artificial substrates, and (d) lowers the ratio of units of ganglioside/units of artificial substrate hydrolyzed by a factor of 3. We concluded that the beta -Pro504 right-arrow Ser mutation directly affects the ability of Hex A to hydrolyze its natural substrate but not its artificial substrates. The effect of the mutation on ganglioside hydrolysis, combined with its effect on intracellular transport, produces chronic Sandhoff disease.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. H. B. Maegawa, M. Tropak, J. Buttner, T. Stockley, F. Kok, J. T. R. Clarke, and D. J. Mahuran
Pyrimethamine as a Potential Pharmacological Chaperone for Late-onset Forms of GM2 Gangliosidosis
J. Biol. Chem., March 23, 2007; 282(12): 9150 - 9161.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Hinek, A. V. Pshezhetsky, M. von Itzstein, and B. Starcher
Lysosomal Sialidase (Neuraminidase-1) Is Targeted to the Cell Surface in a Multiprotein Complex That Facilitates Elastic Fiber Assembly
J. Biol. Chem., February 10, 2006; 281(6): 3698 - 3710.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. B. Tropak, S. P. Reid, M. Guiral, S. G. Withers, and D. Mahuran
Pharmacological Enhancement of {beta}-Hexosaminidase Activity in Fibroblasts from Adult Tay-Sachs and Sandhoff Patients
J. Biol. Chem., April 2, 2004; 279(14): 13478 - 13487.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.